| Inflammation, aging and cancerCentenarians tend to have less robust inflammatory responses. The reduction in inflammatory capacity isn’t large (not even two-fold at the level of primary cytokine output, though quantifying the difference depends ultimately on which endpoint one is measuring), so this gives credence to the idea that tailored anti-inflammatory drugs — perhaps targeted to individual tissues -- could help slow age-related onset of cancers. |
|
|
